Shawna Fox

642 total citations · 1 hit paper
14 papers, 394 citations indexed

About

Shawna Fox is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Shawna Fox has authored 14 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Shawna Fox's work include Cardiomyopathy and Myosin Studies (7 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (5 papers) and Congenital heart defects research (3 papers). Shawna Fox is often cited by papers focused on Cardiomyopathy and Myosin Studies (7 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (5 papers) and Congenital heart defects research (3 papers). Shawna Fox collaborates with scholars based in United States, Spain and Italy. Shawna Fox's co-authors include Sergei G. Tevosian, Maria B. Padua, Tianyu Jiang, Nikolay L. Manuylov, Heather Hatch, William T. Pu, Bin Zhou, Qing Ma, Melissa Black and Yawen Li and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Endocrinology.

In The Last Decade

Shawna Fox

13 papers receiving 391 citations

Hit Papers

Mavacamten Treatment for Symptomatic Obstructive Hypertro... 2024 2026 2025 2024 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    2024 34 citations Florian Rader, Artur Oręziak et al. JACC Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawna Fox United States 9 158 147 114 74 52 14 394
A. Varotto Italy 9 83 0.5× 101 0.7× 25 0.2× 138 1.9× 213 4.1× 13 329
Sinead McGlacken‐Byrne United Kingdom 7 41 0.3× 68 0.5× 8 0.1× 41 0.6× 21 0.4× 18 190
Chuan Xu China 12 106 0.7× 116 0.8× 6 0.1× 112 1.5× 143 2.8× 26 312
Jennifer Willis Canada 10 96 0.6× 111 0.8× 21 0.2× 473 6.4× 595 11.4× 14 724
A. Raziel Israel 8 90 0.6× 122 0.8× 14 0.1× 128 1.7× 207 4.0× 12 286
Heidrun Janka Germany 10 40 0.3× 101 0.7× 6 0.1× 27 0.4× 16 0.3× 26 309
Ron van Golde Netherlands 8 66 0.4× 93 0.6× 6 0.1× 77 1.0× 95 1.8× 17 239
Sarah Irvin United States 7 30 0.2× 34 0.2× 8 0.1× 139 1.9× 14 0.3× 15 291
T Samuel United States 10 78 0.5× 47 0.3× 19 0.2× 44 0.6× 167 3.2× 14 334
Matthew Dapas United States 8 65 0.4× 81 0.6× 18 0.2× 197 2.7× 267 5.1× 13 374

Countries citing papers authored by Shawna Fox

Since Specialization
Citations

This map shows the geographic impact of Shawna Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawna Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawna Fox more than expected).

Fields of papers citing papers by Shawna Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawna Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawna Fox. The network helps show where Shawna Fox may publish in the future.

Co-authorship network of co-authors of Shawna Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Shawna Fox. A scholar is included among the top collaborators of Shawna Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawna Fox. Shawna Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rader, Florian, Artur Oręziak, Lubna Choudhury, et al.. (2024). Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy. JACC Heart Failure. 12(1). 164–177. 34 indexed citations breakdown →
2.
García‐Pavía, Pablo, Artur Oręziak, Ahmad Masri, et al.. (2024). Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy. European Heart Journal. 45(47). 5071–5083. 38 indexed citations
3.
Masri, Ahmad, Steven J. Lester, John C. Stendahl, et al.. (2024). Long‐Term Safety and Efficacy of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results of the PIONEER‐OLE Study. Journal of the American Heart Association. 13(8). e030607–e030607. 14 indexed citations
4.
5.
Masri, Ahmad, Steven J. Lester, John C. Stendahl, et al.. (2023). LONG-TERM SAFETY AND EFFICACY OF MAVACAMTEN IN PATIENTS (PTS) WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM): UPDATED RESULTS FROM THE PIONEER-OLE STUDY. Journal of the American College of Cardiology. 81(8). 346–346. 3 indexed citations
6.
Saberi, Sara, Christopher M. Kramer, Artur Oręziak, et al.. (2023). 96-WEEK CARDIAC MAGNETIC RESONANCE (CMR) RESULTS OF TREATMENT WITH MAVACAMTEN FROM THE EXPLORER COHORT OF THE MAVA-LONG-TERM EXTENSION (LTE) STUDY IN PATIENTS (PTS) WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM). Journal of the American College of Cardiology. 81(8). 326–326. 5 indexed citations
7.
8.
Black, Melissa, Elizabeth J. Anderson, Yawen Li, et al.. (2020). Impact of Telehealth Interventions on Medication Adherence for Patients With Type 2 Diabetes, Hypertension, and/or Dyslipidemia: A Systematic Review. Annals of Pharmacotherapy. 55(5). 637–649. 72 indexed citations
9.
Tevosian, Sergei G., Shawna Fox, & Hans K. Ghayee. (2019). Molecular Mechanisms of Primary Aldosteronism. Endocrinology and Metabolism. 34(4). 355–355. 7 indexed citations
10.
Tevosian, Sergei G., Elizabeth Jiménez, Heather Hatch, et al.. (2015). Adrenal Development in Mice Requires GATA4 and GATA6 Transcription Factors. Endocrinology. 156(7). 2503–2517. 25 indexed citations
11.
12.
Padua, Maria B., et al.. (2014). Simultaneous Gene Deletion of Gata4 and Gata6 Leads to Early Disruption of Follicular Development and Germ Cell Loss in the Murine Ovary1. Biology of Reproduction. 91(1). 24–24. 37 indexed citations
13.
Padua, Maria B., et al.. (2013). The transcription factor GATA4 is required for follicular development and normal ovarian function. Developmental Biology. 381(1). 144–158. 50 indexed citations
14.
Manuylov, Nikolay L., Bin Zhou, Qing Ma, et al.. (2011). Conditional ablation of Gata4 and Fog2 genes in mice reveals their distinct roles in mammalian sexual differentiation. Developmental Biology. 353(2). 229–241. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Varotto Breakdown of academic impact, for papers by Sinead McGlacken‐Byrne Breakdown of academic impact, for papers by Chuan Xu Breakdown of academic impact, for papers by Jennifer Willis Breakdown of academic impact, for papers by A. Raziel Breakdown of academic impact, for papers by Heidrun Janka Breakdown of academic impact, for papers by Ron van Golde Breakdown of academic impact, for papers by Sarah Irvin Breakdown of academic impact, for papers by T Samuel Breakdown of academic impact, for papers by Matthew Dapas
Rankless by CCL
2026